title: Adult orbital xanthogranuloma successfully treated with rituximab.
authors.affiliation: Orbital Plastic and Lacrimal Clinic, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.
authors.forename: Khami
authors.initials: K
authors.lastname: Satchi
authors.affiliation: Orbital Plastic and Lacrimal Clinic, Royal Victorian Eye and Ear Hospital, Melbourne, Australia.
authors.forename: Alan A
authors.initials: AA
authors.lastname: McNab
authors.affiliation: Ocular Immunology Clinic, Royal Victorian Eye and Ear Hospital, and Department of Rheumatology, St Vincent's Hospital Melbourne, Melbourne, Australia.
authors.forename: Timothy
authors.initials: T
authors.lastname: Godfrey
authors.affiliation: Cabrini Health and Monash University, Melbourne, Australia.
authors.forename: H Miles
authors.initials: HM
authors.lastname: Prince
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018951:Antigens, CD20 / Q000276:immunology; D005260:Female; D006099:Granuloma / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009916:Orbital Diseases / Q000188:drug therapy* / Q000503:physiopathology; D000069283:Rituximab; D014792:Visual Acuity / Q000502:physiology; D014973:Xanthomatosis / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D007155:Immunologic Factors; D000069283:Rituximab